INAB

NASD IN8bio, Inc.
Sep 29, 2026 · 9:30 PM ET EOD Market Closed

$1.30 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.30, $0.01 below the day’s high of $1.30

YTD change
-44.66%
vs 20-day SMA
+16.20%
vs 200-day SMA
-16.48%

Price ranges

Previous day
$1.19 $1.30
open $1.19 close $1.24
+$0.05 (+4.20%)
Today
$1.27 $1.30
open $1.28 now $1.30
+$0.01 (+1.17%)
Past week
$1.06 $1.30
from $1.06 now $1.30
+$0.24 (+22.17%)
Past month
$1.01 $1.30
from $1.04 now $1.30
+$0.26 (+25.12%)
This year
$0.88 $2.73
from $2.34 now $1.30
-$1.05 (-44.66%)

Price & Performance

-0.08 (-5.47%) / 6M

$0.8872$1.24$1.59$1.94Mar 30Jun 30Sep 29

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 99.6% away from all-time highs of $309.57
  • INAB is down 45% since the beginning of the year
  • INAB is down 43% over the past 12 months
  • INAB is up 25% over the past 1 month
  • 1% of all INAB investors are betting against INAB

INAB reads very good: price sits above one of the two key moving averages, the 12-month move is -42.7%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.25
Earnings momentum +25.7% Quarterly EPS growth
Quarterly change +25.7%

Valuation

P/E ratio N/A
Enterprise value $8.4M
Beta 1.02

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$18.0M
Debt$2.2K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $12.8M

IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates for solid and liquid tumors and gamma-delta T cell engagers for cancer and autoimmune diseases. The company was founded by Lawrence S. Lamb and William T. Ho on February 8, 2016 and is headquartered in New York, NY.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $423.64 +1.32%
MRNA Moderna, Inc. $203.46 +3.13%
RVMD Revolution Medicines, Inc. $204.48 +1.36%
ROIV Roivant Sciences Ltd. $36.50 -1.30%
BNTX BioNTech SE Sponsored ADR $98.57 -0.51%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.